"ENGINEERED CLOSTRIDIUM BOTULINUM TOXIN ADAPTED TO DELIVER MOLECULES IN" by Benjamin J. Pavlik, Paul Blum et al.

Chemical and Biomolecular Engineering, Department of

 

Date of this Version

2020

Document Type

Article

Citation

United States Patent Pavlik et al. Patent No.: US 10,633,643 B2

Abstract

An engineered payload-delivery system includes a target cell binding unit, covlently bound to a pore forming unit, and a payload portion adapted with a region capable of non-covalently binding to the pore forming unit. The pore forming unit is derived from a particular sub-serotype of Clostridium toxin, while the payload region is derived from a different sub-serotype of Clostridium toxin. The disclosed chimeri protein-based composition is capable of specifically delivering payload to neural cells.

Share

COinS